{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T22:09:20Z","timestamp":1766182160757,"version":"build-2065373602"},"reference-count":36,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejso.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Surgical Oncology"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.ejso.2023.107084","type":"journal-article","created":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T01:20:19Z","timestamp":1696123219000},"page":"107084","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Is routine admission to a critical care setting following hyperthermic intraperitoneal chemotherapy for ovarian cancer necessary?"],"prefix":"10.1016","volume":"49","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3390-3858","authenticated-orcid":false,"given":"Ruby M.","family":"van Stein","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. Lot","family":"Aronson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karolina","family":"Sikorska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Florine J.","family":"Hendriks","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Els P.","family":"Hovinga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4782-0068","authenticated-orcid":false,"given":"Aletta P.I.","family":"Houwink","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter F.E.","family":"Schutte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maaike S.","family":"Schooneveldt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cor D.","family":"De Kroon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabe S.","family":"Sonke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2246-1994","authenticated-orcid":false,"given":"Willemien J.","family":"van Driel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.ejso.2023.107084_bib1","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1056\/NEJMoa1708618","article-title":"Hyperthermic intraperitoneal chemotherapy in ovarian cancer","volume":"378","author":"van Driel","year":"2018","journal-title":"N\u00a0Engl J Med"},{"issue":"5","key":"10.1016\/j.ejso.2023.107084_bib2","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1001\/jamasurg.2022.0143","article-title":"Survival after hyperthermic intraperitoneal chemotherapy and primary or interval cytoreductive surgery in ovarian cancer: a randomized clinical trial","volume":"157","author":"Lim","year":"2022","journal-title":"JAMA Surgery"},{"issue":"2","key":"10.1016\/j.ejso.2023.107084_bib3","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1007\/s13193-016-0508-2","article-title":"Anaesthetic considerations in the perioperative management of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy","volume":"7","author":"Sheshadri","year":"2016","journal-title":"Indian J Surg Oncol"},{"issue":"2","key":"10.1016\/j.ejso.2023.107084_bib4","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1007\/s13193-016-0511-7","article-title":"Intensive care management of patient after cytoreductive surgery and HIPEC - a concise review","volume":"7","author":"Padmakumar","year":"2016","journal-title":"Indian J Surg Oncol"},{"issue":"4","key":"10.1016\/j.ejso.2023.107084_bib5","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1213\/ANE.0b013e3182860fff","article-title":"An overview of cytoreductive surgery and hyperthermic intraperitoneal chemoperfusion for the anesthesiologist","volume":"116","author":"Webb","year":"2013","journal-title":"Anesth Analg"},{"issue":"3","key":"10.1016\/j.ejso.2023.107084_bib6","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1097\/ACO.0b013e32835347b2","article-title":"Anesthetic management in patients undergoing hyperthermic chemotherapy","volume":"25","author":"Raspe","year":"2012","journal-title":"Curr Opin Anaesthesiol"},{"issue":"1","key":"10.1016\/j.ejso.2023.107084_bib7","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.jval.2011.09.007","article-title":"Direct cost analysis of intensive care unit stay in four European countries: applying a standardized costing methodology","volume":"15","author":"Tan","year":"2012","journal-title":"Value Health"},{"issue":"4","key":"10.1016\/j.ejso.2023.107084_bib8","doi-asserted-by":"crossref","first-page":"263","DOI":"10.2165\/00019053-200321040-00004","article-title":"Unit costs of inpatient hospital days","volume":"21","author":"Oostenbrink","year":"2003","journal-title":"Pharmacoeconomics"},{"issue":"12","key":"10.1016\/j.ejso.2023.107084_bib9","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1093\/bjs\/znac301","article-title":"Impact of the COVID-19 pandemic on surgical care in The Netherlands","volume":"109","author":"de Graaff","year":"2022","journal-title":"Br J Surg"},{"key":"10.1016\/j.ejso.2023.107084_bib10","doi-asserted-by":"crossref","first-page":"P376","DOI":"10.1186\/cc14456","article-title":"ICU outcome of patients undergoing cytoreductive surgery followed by hyperthermic intraperitoneal chemotherapy: a single-center study","volume":"19","author":"Nadeem","year":"2015","journal-title":"Crit Care"},{"issue":"1","key":"10.1016\/j.ejso.2023.107084_bib11","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.asjsur.2021.06.003","article-title":"Effect of the learning curve of cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) on the treatment of colorectal peritoneal metastasis","volume":"45","author":"Chidambarasamy","year":"2022","journal-title":"Asian J Surg"},{"issue":"10","key":"10.1016\/j.ejso.2023.107084_bib12","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/j.ejso.2009.02.010","article-title":"Quantitative intra-operative assessment of peritoneal carcinomatosis - a comparison of three prognostic tools","volume":"35","author":"Swellengrebel","year":"2009","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.ejso.2023.107084_bib13","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/978-1-4613-1247-5_23","article-title":"Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis","volume":"82","author":"Jacquet","year":"1996","journal-title":"Cancer Treat Res"},{"issue":"1","key":"10.1016\/j.ejso.2023.107084_bib14","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/00000658-199501000-00004","article-title":"Peritonectomy procedures","volume":"221","author":"Sugarbaker","year":"1995","journal-title":"Ann Surg"},{"issue":"4","key":"10.1016\/j.ejso.2023.107084_bib15","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.jamcollsurg.2009.01.006","article-title":"Quality improvement in the surgical approach to advanced ovarian cancer: the Mayo Clinic experience","volume":"208","author":"Aletti","year":"2009","journal-title":"J\u00a0Am Coll Surg"},{"issue":"4","key":"10.1016\/j.ejso.2023.107084_bib16","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1136\/ijgc-2019-000356","article-title":"Guidelines for perioperative care in gynecologic\/oncology: enhanced Recovery after Surgery (ERAS) Society recommendations-2019 update","volume":"29","author":"Nelson","year":"2019","journal-title":"Int J Gynecol Cancer"},{"issue":"4","key":"10.1016\/j.ejso.2023.107084_bib17","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1007\/s11605-015-2743-1","article-title":"A\u00a0randomized trial of goal directed vs. standard fluid therapy in cytoreductive surgery with hyperthermic intraperitoneal chemotherapy","volume":"19","author":"Colantonio","year":"2015","journal-title":"J\u00a0Gastrointest Surg"},{"issue":"12","key":"10.1016\/j.ejso.2023.107084_bib18","doi-asserted-by":"crossref","first-page":"972","DOI":"10.4103\/ija.IJA_765_19","article-title":"Society of Onco-Anaesthesia and Perioperative Care consensus guidelines for perioperative management of patients for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS-HIPEC)","volume":"63","author":"Solanki","year":"2019","journal-title":"Indian J Anaesth"},{"key":"10.1016\/j.ejso.2023.107084_bib19","article-title":"Standardizing HIPEC and perioperative care for patients with ovarian cancer in The Netherlands using a Delphi-based consensus","volume":"39","author":"van Stein","year":"2022","journal-title":"Gynecol Oncol Rep"},{"issue":"3","key":"10.1016\/j.ejso.2023.107084_bib20","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1097\/00003246-199903000-00048","article-title":"Guidelines for intensive care unit admission, discharge, and triage. Task force of the American college of critical care medicine, society of critical care medicine","volume":"27","year":"1999","journal-title":"Crit Care Med"},{"year":"1996","series-title":"Guidelines on admission to and discharge from intensive care and high dependency units","key":"10.1016\/j.ejso.2023.107084_bib21"},{"key":"10.1016\/j.ejso.2023.107084_bib22","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1186\/1477-7819-9-169","article-title":"Post-operative critical care management of patients undergoing cytoreductive surgery and heated intraperitoneal chemotherapy (HIPEC)","volume":"9","author":"Cooksley","year":"2011","journal-title":"World J Surg Oncol"},{"issue":"2","key":"10.1016\/j.ejso.2023.107084_bib23","doi-asserted-by":"crossref","first-page":"116","DOI":"10.5492\/wjccm.v6.i2.116","article-title":"Critical care management and intensive care unit outcomes following cytoreductive surgery with hyperthermic intraperitoneal chemotherapy","volume":"6","author":"Kapoor","year":"2017","journal-title":"World J Crit Care Med"},{"issue":"1","key":"10.1016\/j.ejso.2023.107084_bib24","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.suronc.2015.11.003","article-title":"Complications after cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for treatment of peritoneal carcinomatosis: risk factors for ICU admission and morbidity prognostic score","volume":"25","author":"Malfroy","year":"2016","journal-title":"Surg Oncol"},{"issue":"2","key":"10.1016\/j.ejso.2023.107084_bib25","doi-asserted-by":"crossref","first-page":"235","DOI":"10.21037\/jgo.2018.12.11","article-title":"The effect of intraoperative fluid administration on outcomes of patients undergoing cytoreductive surgery with hyperthermic intraperitoneal chemotherapy","volume":"10","author":"Shamavonian","year":"2019","journal-title":"J\u00a0Gastrointest Oncol"},{"issue":"12","key":"10.1016\/j.ejso.2023.107084_bib26","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1001\/jamasurg.2017.2865","article-title":"Association of fluid administration with morbidity in cytoreductive surgery with hyperthermic intraperitoneal chemotherapy","volume":"152","author":"Eng","year":"2017","journal-title":"JAMA Surgery"},{"issue":"4","key":"10.1016\/j.ejso.2023.107084_bib27","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/j.1365-2044.2007.05380.x","article-title":"Peri-operative anaesthetic management of cytoreductive surgery with hyperthermic intraperitoneal chemotherapy","volume":"63","author":"Schmidt","year":"2008","journal-title":"Anaesthesia"},{"key":"10.1016\/j.ejso.2023.107084_bib28","doi-asserted-by":"crossref","DOI":"10.1177\/00031348211050588","article-title":"Early postoperative extubation is associated with shorter hospitalization and improved short-term survival in patients undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy","author":"Hendrick","year":"2022","journal-title":"Am Surg"},{"issue":"3","key":"10.1016\/j.ejso.2023.107084_bib29","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/j.ygyno.2020.06.487","article-title":"A\u00a0guide to establishing a hyperthermic intraperitoneal chemotherapy program in gynecologic oncology","volume":"158","author":"Chambers","year":"2020","journal-title":"Gynecol Oncol"},{"issue":"4","key":"10.1016\/j.ejso.2023.107084_bib30","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.egja.2013.05.005","article-title":"The perioperative course and anesthetic challenge for cytoreductive surgery with hyperthermic intraperitoneal chemotherapy","volume":"29","author":"Kamal","year":"2013","journal-title":"Egypt J Anaesth"},{"issue":"2","key":"10.1016\/j.ejso.2023.107084_bib31","first-page":"47","article-title":"peritoneum","volume":"2","author":"de Bree","year":"2017","journal-title":"Pharmacological principles of intraperitoneal and bidirectional chemotherapy"},{"issue":"2","key":"10.1016\/j.ejso.2023.107084_bib32","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1097\/CJ9.0000000000000025","article-title":"Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy: main concepts for anesthetists","volume":"46","author":"Escobar","year":"2018","journal-title":"Colombian Journal of Anesthesiology"},{"issue":"5","key":"10.1016\/j.ejso.2023.107084_bib33","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1245\/s10434-015-4963-8","article-title":"Routine admission to intensive care unit after cytoreductive surgery and heated intraperitoneal chemotherapy: not always a requirement","volume":"23","author":"Mogal","year":"2016","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2023.107084_bib34","article-title":"Intensive care unit admission after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Is it necessary?","volume":"2014","author":"L\u00f3pez-Basave","year":"2014","journal-title":"JAMA Oncol"},{"issue":"3","key":"10.1016\/j.ejso.2023.107084_bib35","first-page":"726","article-title":"Intensive care unit hospitalization after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy","volume":"21","author":"Spiliotis","year":"2016","journal-title":"J\u00a0buon"},{"issue":"24","key":"10.1016\/j.ejso.2023.107084_bib36","doi-asserted-by":"crossref","first-page":"5256","DOI":"10.1002\/cncr.33167","article-title":"Hyperthermic intraperitoneal chemotherapy in interval debulking surgery for advanced epithelial ovarian cancer: a single-center, real-life experience","volume":"126","author":"Ghirardi","year":"2020","journal-title":"Cancer"}],"container-title":["European Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798323007229?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798323007229?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T01:47:40Z","timestamp":1760060860000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0748798323007229"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":36,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["S0748798323007229"],"URL":"https:\/\/doi.org\/10.1016\/j.ejso.2023.107084","relation":{},"ISSN":["0748-7983"],"issn-type":[{"type":"print","value":"0748-7983"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Is routine admission to a critical care setting following hyperthermic intraperitoneal chemotherapy for ovarian cancer necessary?","name":"articletitle","label":"Article Title"},{"value":"European Journal of Surgical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejso.2023.107084","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd, BASO ~ The Association for Cancer Surgery, and the European Society of Surgical Oncology. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"107084"}}